← Back to Search

N/A

Pecans for Cardiovascular Health

Phase 2
Waitlist Available
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of ≥ 1 criterion for metabolic syndrome at screening (i.e., waist circumference ≥ 94 cm men or ≥ 80 cm women; triglycerides ≥150 mg/dL; HDL-cholesterol ≤ 40 mg/dL men or ≤ 50 mg/dL women; systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg; fasting plasma glucose ≥100 mg/dL)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will examine whether pecans have an effect on markers of peripheral vascular health, lipids and lipoproteins, blood pressure, and glycemic control.

Who is the study for?
This trial is for adults with at least one sign of metabolic syndrome, such as a large waistline or high blood pressure, and a BMI between 25-40. Smokers, pregnant women, those with diabetes or severe hypertension, recent alcohol or antibiotic use are excluded. Also ineligible are individuals with unstable weight, cardiovascular events history, liver/kidney diseases.Check my eligibility
What is being tested?
The study is testing if eating pecans affects heart and blood vessel health compared to usual care without pecans. Participants will be randomly assigned to two groups: one adding pecans to their diet and the other continuing their normal routine.See study design
What are the potential side effects?
Since this trial involves consuming pecans as part of the diet rather than medication, side effects may include potential allergic reactions in those sensitive to nuts or gastrointestinal discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I meet at least one condition for metabolic syndrome.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Flow Mediated Dilation
Secondary outcome measures
Augmentation Index
Brachial systolic and diastolic blood pressure
Carotid-femoral pulse wave velocity
+11 more
Other outcome measures
Change in the composition of the gut microbiota

Trial Design

2Treatment groups
Active Control
Group I: Pecan GroupActive Control1 Intervention
Participants will consume their usual diet, but replace one snack with unsalted raw pecans incorporated as a snack
Group II: Usual Care GroupActive Control1 Intervention
Participants will consume their usual diet devoid of nuts

Find a Location

Who is running the clinical trial?

American Pecan CouncilOTHER
2 Previous Clinical Trials
71 Total Patients Enrolled
Penn State UniversityLead Sponsor
357 Previous Clinical Trials
125,849 Total Patients Enrolled

Media Library

Pecans (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT05071807 — Phase 2
Cardiovascular Disease Research Study Groups: Pecan Group, Usual Care Group
Cardiovascular Disease Clinical Trial 2023: Pecans Highlights & Side Effects. Trial Name: NCT05071807 — Phase 2
Pecans (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05071807 — Phase 2
~50 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top